Peroxisome proliferator‐activated receptor γ agonist efatutazone impairs transforming growth factor β2‐induced motility of epidermal growth factor receptor tyrosine kinase inhibitor‐resistant lung cancer cells
2016 ◽
Vol 79
(5)
◽
pp. 248-255
◽